Clinical Trials Using STING-activating Cyclic Dinucleotide Agonist MIW815

Clinical trials are research studies that involve people. The clinical trials on this list are studying STING-activating Cyclic Dinucleotide Agonist MIW815. All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trial 1 of 1
  • Efficacy and Safety Trial of ADU-S100 and Pembrolizumab in Head and Neck Cancer

    ADU-CL-20 is an open-label, multicenter Phase 2 clinical trial to evaluate the efficacy and safety of intratumoral ADU-S100 (also referred to as MIW815) administered with pembrolizumab in the first-line setting. The population will consist of adults with PD-L1 positive recurrent or metastatic HNSCC.
    Location: 12 locations